Trends of diabetic nephropathy prevalence in Isfahan, Iran, during 1992-2010

Background: Diabetes mellitus is a metabolic disorder and its subsequent complications such as retinopathy, nephropathy, ulcers, disability, and amputation increase the burden of the disease. Patient knowledge-improving programs are employed to prevent disease progression and to improve the quality of life of the patients. In this way, we need to characterize the groups of patients in urgent need for more and rich-in-content programs. In the present study, we used piecewise regression to evaluate the trends of diabetic nephropathy prevalence in patients registered in the Sedigheh-Tahereh Research Center and to identify patients who were in need of more attention. Materials and Methods: Piecewise regression, used in this study, is a statistical method to identify change points, if any, in the trends of mortality rates, prevalence of a disease, or any other trends. Available information for 1,935 patients were retrieved from the database. Joinpoint program 3.5.3 and Statistical Package for the Social Sciences (SPSS) 20 was used to fit piecewise regression and obtain descriptive statistics, respectively. Results: We assessed the trend of diabetic nephropathy in different groups of diabetic patients with respect to sex, blood pressure status, education, family history of diabetes, and age. The results showed an increasing trend in females, patients without family history of diabetes, and eover th recent years. The prevalence of diabetic nephropathy in patients with academic education was high. Conclusion: The groups with high prevalence or increasing trends need more preventive intervention and detailed assessment of the present trends. Exploring high-risk groups is beneficial for better policy-making in the future. However, discovering the reasons for the increased trend of the disease is really helpful in controlling diabetes complications.

[1]  A. Ernest,et al.  Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania , 2016, BMC Nephrology.

[2]  K. Tuttle,et al.  Novel therapies for diabetic kidney disease. , 2013, Advances in chronic kidney disease.

[3]  G. Kishore,et al.  Risk factors and management of diabetic nephropathy. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[4]  A. Al-Agha,et al.  Occurrence of microalbuminuria among children and adolescents with insulin-dependent diabetes mellitus. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[5]  C. Thompson Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. , 2013, World journal of diabetes.

[6]  Zhaohu Hao,et al.  [Analyses on the relative factors regarding diabetic nephropathy]. , 2013, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[7]  Nan Chen,et al.  Prevalence of chronic kidney disease in China: a cross-sectional survey , 2012, The Lancet.

[8]  F. Amani,et al.  Applying Segmented Regression Model to Analysis the Trend of Tuberculosis Incidence Rate in Iran Between 1964 -2008 , 2011 .

[9]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[10]  Chris Jones Biomarkers of Kidney Disease , 2011 .

[11]  Zumin Shi Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[12]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[13]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[14]  Chih-Cheng Hsu,et al.  High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  K. Land,et al.  A Mixed Models Approach to the Age-Period-Cohort Analysis of Repeated Cross-Section Surveys, with an Application to Data on Trends in Verbal Test Scores , 2006 .

[16]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[17]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[18]  S. Haghighi,et al.  Costs of type 2 Diabetes in Isfahan – Iran in 1998 , 2002 .

[19]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[20]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[21]  B. Freedman,et al.  Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.

[22]  J. Himmelfarb,et al.  New therapies for diabetic kidney disease. , 2013, The New England journal of medicine.

[23]  H. Alireza,et al.  ECONOMICS COST OF DIABETES IN TYPE II DIABETIC PATIENTS , 2012 .

[24]  Sharifirad Gholamreza,et al.  THE RELATIONSHIP BETWEEN SOCIOECONOMIC FACTORS AND THEIR EFFECTS ON PATIENTS WITH TYPE 2 DIABETES , 2011 .

[25]  C. Edelstein Biomarkers in kidney disease , 2011 .